Risk of cancer in autoimmune pancreatitis: A case-control study and review of the literature

Pancreas

Volumn 43, Issue 3, 2014, Pages 417-421

  Hart, Phil A ^a   Law, Ryan J ^a   Dierkhising, Ross A ^a   Smyrk, Thomas C ^a   Takahashi, Naoki ^a   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune pancreatitis; Cancer; IgG4 related disease; Pancreatic cancer

Indexed keywords

ADULT; AUTOIMMUNE PANCREATITIS; BILE DUCT CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SALIVARY GLAND CANCER; AUTOIMMUNE DISEASES; COMPLICATION; DIFFERENTIAL DIAGNOSIS; LITERATURE; NEOPLASMS; PANCREATITIS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; URINARY BLADDER NEOPLASMS;

AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; PANCREATITIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; REVIEW LITERATURE AS TOPIC; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS;

EID: 84896682486     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000053     Document Type: Review

References (40)

1. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): General concept and details. Mod Rheumatol. 2012;22:1-14.
2. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328:1433-1437.
3. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070-2075.
4. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: Clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119-1127.
5. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140-148.
6. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
7. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114-1117.
8. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: A previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159-1167.
9. Gill J, Angelo N, Yeong ML, et al. Salivary duct carcinoma arising in IgG4-related autoimmune disease of the parotid gland. Hum Pathol. 2009;40:881-886.
10. Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465-470.
11. Takahashi N, Ghazale AH, Smyrk TC, et al. Possible association between IgG4-Associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523-526.
12. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414-418.
13. Blechacz B, Gores GJ. Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308-321.
14. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31:1586-1597.
15. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitisYassociated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis?. Am J Surg Pathol. 2004;28:1193-1203.
16. Zen Y, Kasahara Y, Horita K, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: Histologic similarity to sclerosing pancreatitis. Am J Surg Pathol. 2005;29:275-278.
17. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710-717.
18. Hart PA, Moyer AM, Yi ES, et al. IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: An extrapancreatic manifestation of IgG4-related disease. Hum Pathol. 2012;43:2084-2087.
19. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610-617.
20. Fukui T, Mitsuyama T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med. 2008;47:151-155.
21. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer?. Pancreas. 2007;35:376.
22. Hirano K, Tada M, Isayama H, et al. Long-Term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719-1724.
23. Inoue H, Miyatani H, Sawada Y, et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas. 2006;33:208-209.
24. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-1507.
25. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142-1151.
26. Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009;59:744-747.
27. Pezzilli R, Vecchiarelli S, Di Marco MC, et al. Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case Rep Gastroenterol. 2011;5:378-385.
28. Uchida K, Yazumi S, Nishio A, et al. Long-Term outcome of autoimmune pancreatitis. J Gastroenterol. 2009;44:726-732.
29. Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: Case report and review of the literature. Hum Pathol. 2008;39:1548-1551.
30. Hayashi M, Arisaka Y, Takeshita A, et al. Differential diagnosis of pancreatobiliary carcinoma from autoimmune pancreatitisYrelated diseases: A report of three cases. J Gastrointest Cancer. 2011;42:241-251.
31. Straub BK, Esposito I, Gotthardt D, et al. IgG4-Associated cholangitis with cholangiocarcinoma. Virchows Arch. 2011;458:761-765.
32. Kawa S, Hamano H, Ozaki Y, et al. Long-Term follow-up of autoimmune pancreatitis: Characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009;7:S18-22.
33. Loos M, Esposito I, Hedderich DM, et al. Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system: A case report and review of the literature. Pancreas. 2011;40:151-154.
34. Kanda G, Ryu T, Shirai T, et al. Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med. 2011;50:155-160.
35. Nishino T, Toki F, Oyama H, et al. Long-Term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497-501.
36. Arai O, Matsueda K, Katayama S, et al. Case of autoimmune pancreatitis with various extrapancreatic fibrosclerosis followed by malignant diseases. Nihon Shokakibyo Gakkai Zasshi. 2008;105:711-718.
37. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol. 2007;42(suppl 18):59-62.
38. Kim T, Grobmyer SR, Dixon LR, et al. Autoimmune pancreatitis and concurrent small lymphocytic lymphoma: Not just a coincidence?. J Gastrointest Surg. 2008;12:1566-1570.
39. Tabata R, Tabata C, Okamoto T, et al. Autoimmune pancreatitis associated with myelodysplastic syndrome. Int Arch Allergy Immunol. 2010;151:168-172.
40. Ito M, Naruke Y, Mihara Y, et al. Thyroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease. Pathol Int. 2011;61:589-592.